Mirabella Financial Services LLP Purchases 10,298 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Mirabella Financial Services LLP raised its position in shares of Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 328.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,433 shares of the company's stock after purchasing an additional 10,298 shares during the period. Mirabella Financial Services LLP's holdings in Church & Dwight were worth $1,406,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CHD. YANKCOM Partnership acquired a new position in shares of Church & Dwight during the fourth quarter worth $25,000. Versant Capital Management Inc lifted its holdings in Church & Dwight by 224.4% during the 4th quarter. Versant Capital Management Inc now owns 266 shares of the company's stock worth $28,000 after buying an additional 184 shares during the period. Strategic Financial Concepts LLC acquired a new position in Church & Dwight during the 4th quarter worth about $39,000. Bernard Wealth Management Corp. bought a new stake in shares of Church & Dwight in the 4th quarter valued at about $40,000. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of Church & Dwight in the fourth quarter valued at about $43,000. 86.60% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CHD has been the topic of several analyst reports. Bank of America upgraded Church & Dwight from a "neutral" rating to a "buy" rating and upped their target price for the company from $112.00 to $125.00 in a report on Tuesday, April 15th. Stifel Nicolaus upped their price objective on shares of Church & Dwight from $103.00 to $105.00 and gave the company a "hold" rating in a research note on Monday, February 3rd. Barclays dropped their target price on shares of Church & Dwight from $97.00 to $94.00 and set an "underweight" rating on the stock in a report on Friday, April 11th. JPMorgan Chase & Co. lowered their price objective on Church & Dwight from $106.00 to $98.00 and set an "underweight" rating for the company in a research report on Friday, April 11th. Finally, Piper Sandler cut their target price on Church & Dwight from $128.00 to $126.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $112.13.

Insider Transactions at Church & Dwight

In related news, EVP Maynadier Patrick D. De sold 54,510 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $115.98, for a total value of $6,322,069.80. Following the transaction, the executive vice president now owns 10,497 shares of the company's stock, valued at approximately $1,217,442.06. This trade represents a 83.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Rene Hemsey sold 11,060 shares of Church & Dwight stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $109.98, for a total transaction of $1,216,378.80. Following the transaction, the executive vice president now owns 6,437 shares in the company, valued at $707,941.26. This represents a 63.21 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 65,570 shares of company stock worth $7,538,449 over the last three months. 2.00% of the stock is currently owned by company insiders.

Church & Dwight Trading Down 2.0 %

Shares of Church & Dwight stock traded down $2.00 during midday trading on Thursday, reaching $100.13. 2,662,763 shares of the company's stock traded hands, compared to its average volume of 1,535,778. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. The stock has a 50 day moving average of $107.04 and a 200-day moving average of $106.10. The company has a market cap of $24.64 billion, a PE ratio of 42.25, a price-to-earnings-growth ratio of 3.32 and a beta of 0.55. Church & Dwight Co., Inc. has a 12 month low of $96.35 and a 12 month high of $116.46.

Church & Dwight (NYSE:CHD - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same period in the prior year, the business earned $0.65 earnings per share. As a group, equities analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Friday, February 14th were issued a dividend of $0.295 per share. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date of this dividend was Friday, February 14th. This is an increase from Church & Dwight's previous quarterly dividend of $0.28. Church & Dwight's dividend payout ratio (DPR) is presently 49.79%.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.